Wellbutrin SR | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Wellbutrin SR
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Bupropion Hydrochloride

Contact Supplier

pharmacompass-1-m-2026-01-12

PharmaCompass Sponsored Ads

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-2026-02-09

Wellbutrin SR

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

83 API Suppliers, 38 USDMF, 14 EU WC, 11 KDMF, 35 NDC API, 39 Listed Suppliers, $ API Reference Price

83 API Suppliers
38 USDMF
14 EU WC
11 KDMF
35 NDC API
39 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

248 FDF Dossiers, 138 FDA Orange Book, 58 Europe, 12 Canada, 2 Australia, 17 South Africa, 21 Listed Dossiers

248 FDF Dossiers
138 FDA Orange Book
58 Europe
12 Canada
2 Australia
17 South Africa
21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 300MG, TABLET, EXTENDED RELEASE;ORAL - 450MG

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG
TABLET, EXTENDED RELEASE;ORAL - 100MG
TABLET, EXTENDED RELEASE;ORAL - 150MG
TABLET, EXTENDED RELEASE;ORAL - 200MG
TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 150MG
TABLET, EXTENDED RELEASE;ORAL - 300MG
TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 3 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Capital Farma, 6 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 35 BASF, 1 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures, 3 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 21 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 74 Coating Systems & Additives, 45 Controlled & Modified Release, 43 Direct Compression, 39 Solubilizers, 35 Granulation, 33 Thickeners and Stabilizers, 28 Lubricants & Glidants, 28 Film Formers & Plasticizers, 28 Taste Masking, 24 Parenteral, 23 Topical, 19 Chewable & Orodispersible Aids, 17 Disintegrants & Superdisintegrants, 13 Co-Processed Excipients, 10 Emulsifying Agents, 7 API Stability Enhancers, 6 Rheology Modifiers, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents

78 Fillers, Diluents & Binders
74 Coating Systems & Additives
45 Controlled & Modified Release
43 Direct Compression
39 Solubilizers
35 Granulation
33 Thickeners and Stabilizers
28 Lubricants & Glidants
28 Film Formers & Plasticizers
28 Taste Masking
24 Parenteral
23 Topical
19 Chewable & Orodispersible Aids
17 Disintegrants & Superdisintegrants
13 Co-Processed Excipients
10 Emulsifying Agents
7 API Stability Enhancers
6 Rheology Modifiers
6 Surfactant & Foaming Agents
5 Empty Capsules
4 Vegetarian Capsules
2 Coloring Agents

DIGITAL CONTENT

97 News #PharmaBuzz

97 News #PharmaBuzz

GLOBAL SALES INFORMATION

58 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 10 Annual Reports

58 US Medicaid Prescriptions
46 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

12 APIs, 2 FDF Dossiers

12 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 26 Health Canada Patents

20 US Patents
26 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 25 Others

4 USP
25 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 61 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

26 All

01 6Bausch Health, Canada Inc.

02 8GlaxoSmithKline Inc.

03 11Valeant Canada LP

04 1Biovail Pharmaceuticals Canada

filter Patent Reset all filters

26 All

01 102142320

02 102168364

03 12522708

04 22524300

05 12668884

06 12668885

07 12932127

filter Product Reset all filters

26 All

01 4BUPROPION HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE

02 22Bupropion Hydrochloride

filter Dosage Reset all filters

26 All

01 8Sustained Release Tablet

02 4TABLET (EXTENDED-RELEASE)

03 8Tablet

04 3Tablet (extended release)

05 3tablet (extended release)

filter Exp Date Reset all filters

26 All

01 102013-08-13

02 102014-07-29

03 22023-08-08

04 12024-04-21

05 22027-11-08

06 12034-12-04

Product Main Page

01

Bausch Health, Canada Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

Bausch Health, Canada Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-08-08

Date Granted : 2008-10-28

Bupropion Hydrochloride

Brand Name : WELLBUTRIN XL

Patent Number : 2524300

Filing Date : 2003-08-08

Strength per Unit : 150 mg

Dosage Form : Tablet (extended release)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-08-08

Date Granted : 2008-10-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bausch Health, Canada Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

Bausch Health, Canada Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-08-08

Date Granted : 2008-10-28

Bupropion Hydrochloride

Brand Name : WELLBUTRIN XL

Patent Number : 2524300

Filing Date : 2003-08-08

Strength per Unit : 300 mg

Dosage Form : tablet (extended release)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-08-08

Date Granted : 2008-10-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

GlaxoSmithKline Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-08-13

Date Granted : 2001-10-09

Bupropion Hydrochloride

Brand Name : QUOMEM

Patent Number : 2142320

Filing Date : 1993-08-13

Strength per Unit : 150mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-08-13

Date Granted : 2001-10-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

GlaxoSmithKline Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-07-29

Date Granted : 2001-09-18

Bupropion Hydrochloride

Brand Name : QUOMEM

Patent Number : 2168364

Filing Date : 1994-07-29

Strength per Unit : 150mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-07-29

Date Granted : 2001-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GlaxoSmithKline Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

GlaxoSmithKline Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-08-13

Date Granted : 2001-10-09

Bupropion Hydrochloride

Brand Name : PROLEV

Patent Number : 2142320

Filing Date : 1993-08-13

Strength per Unit : 50mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-08-13

Date Granted : 2001-10-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GlaxoSmithKline Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

GlaxoSmithKline Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-07-29

Date Granted : 2001-09-18

Bupropion Hydrochloride

Brand Name : PROLEV

Patent Number : 2168364

Filing Date : 1994-07-29

Strength per Unit : 50mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-07-29

Date Granted : 2001-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

GlaxoSmithKline Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

GlaxoSmithKline Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-08-13

Date Granted : 2001-10-09

Bupropion Hydrochloride

Brand Name : PROLEV

Patent Number : 2142320

Filing Date : 1993-08-13

Strength per Unit : 100mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-08-13

Date Granted : 2001-10-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

GlaxoSmithKline Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

GlaxoSmithKline Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-07-29

Date Granted : 2001-09-18

Bupropion Hydrochloride

Brand Name : PROLEV

Patent Number : 2168364

Filing Date : 1994-07-29

Strength per Unit : 100mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-07-29

Date Granted : 2001-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

GlaxoSmithKline Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

GlaxoSmithKline Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-08-13

Date Granted : 2001-10-09

Bupropion Hydrochloride

Brand Name : PROLEV

Patent Number : 2142320

Filing Date : 1993-08-13

Strength per Unit : 150mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-08-13

Date Granted : 2001-10-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

GlaxoSmithKline Inc.

Bupropion Hydrochloride

ASPEN

Not Confirmed

GlaxoSmithKline Inc.

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-07-29

Date Granted : 2001-09-18

Bupropion Hydrochloride

Brand Name : PROLEV

Patent Number : 2168364

Filing Date : 1994-07-29

Strength per Unit : 150mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-07-29

Date Granted : 2001-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.